Clinical Trial Update: Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition [Phase 1]

View source ↗

Summary

Phase 1 study update reports pharmacokinetics and safety/tolerability of oral CKD-387 and D635 under fed conditions in individuals with Type 2 diabetes mellitus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CKD-387
• D635

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: UNKNOWN